| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| North America | | 1.2 | 0.2 | | | |
| Asia Pacific | | 4.8 | 1.9 | 1.2 | 0.0 | 0.4 |
| Europe | | 0.6 | 0.3 | 0.5 | 0.0 | 0.7 |
| Other | | | | 0.0 | 1.4 | 0.0 |
| Total revenues | 3.4 | 6.5 | 2.4 | 1.7 | 1.4 | 1.1 |
| Revenue growth [+] | -48.6% | 172.1% | 44.3% | 21.3% | 23.5% | |
| North America | | 382.1% | | | | |
| Asia Pacific | | 161.0% | 55.9% | 142226.1% | -99.8% | |
| Europe | | 76.8% | -31.1% | 85453.5% | -99.9% | |
| United States | | | | 328471.4% | -100.0% | |
| Cost of goods sold | 3.0 | 4.7 | 2.0 | 1.7 | 1.6 | 1.3 |
| Gross profit | 0.4 | 1.9 | 0.4 | -0.1 | -0.2 | -0.2 |
| Gross margin | 11.7% | 28.5% | 17.8% | -4.3% | -17.3% | -14.3% |
| Selling, general and administrative [+] | 11.3 | 8.1 | 7.1 | 5.7 | 6.5 | 3.0 |
| Sales and marketing | 6.1 | 4.1 | 3.0 | 2.8 | 2.8 | 1.6 |
| General and administrative | 5.2 | 4.0 | 4.2 | 2.8 | 3.7 | 1.4 |
| Research and development | 7.1 | 5.2 | 4.6 | 5.4 | 4.9 | 3.7 |
| EBITDA [+] | | -11.4 | -11.2 | -11.1 | -11.5 | -6.8 |
| EBITDA growth | 57.8% | 1.9% | 1.4% | -3.7% | 69.6% | |
| EBITDA margin | -536.2% | -174.8% | -466.8% | -664.5% | -836.7% | -609.0% |
| Depreciation | | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| EBITA | -18.0 | -11.5 | -11.3 | -11.1 | -11.5 | -6.8 |
| EBITA margin | -536.2% | -176.0% | -469.5% | -667.9% | -839.7% | -614.3% |
| Amortization of intangibles | | | | 0.0 | 0.0 | 0.0 |
| EBIT [+] | -18.0 | -11.5 | -11.3 | -11.2 | -11.6 | -6.8 |
| EBIT growth | 56.8% | 2.0% | 1.1% | -3.5% | 69.1% | |
| EBIT margin | -536.2% | -176.0% | -469.5% | -669.9% | -842.1% | -614.8% |
| Interest expense | 0.9 | 0.0 | 1.4 | | 33.5 | 14.7 |
| Interest expense | 0.9 | 0.0 | 1.4 | | 33.5 | 14.7 |
| Other income (expense), net [+] | 2.8 | -0.3 | 0.0 | -0.9 | -22.3 | -4.1 |
| Gain (loss) on debt retirement | | | | | | 0.6 |
| Unrealized gain/loss on derivatives | 0.0 | | 0.0 | 0.0 | -14.3 | -9.0 |
| Change in fair value of warrants | 0.0 | | 0.0 | 0.2 | -8.1 | 4.3 |
| Other | | 0.0 | 0.0 | -0.9 | 0.1 | |
| Pre-tax income | -16.1 | -11.8 | -12.7 | -12.0 | -67.3 | -25.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | 0.0 | -13.0 | -12.9 | -12.1 | -67.4 | -25.7 |
| Net margin | -0.5% | -199.4% | -537.4% | -725.9% | -4902.3% | -2305.3% |
| |
| Basic EPS [+] | ($82.89) | ($1.05) | ($2.47) | ($12.75) | ($9.96) | ($75.89) |
| Growth | 7779.5% | -57.4% | -80.6% | 28.0% | -86.9% | |
| Diluted EPS [+] | ($82.89) | ($1.05) | ($2.47) | ($12.75) | ($9.96) | ($75.89) |
| Growth | 7779.5% | -57.4% | -80.6% | 28.0% | -86.9% | |
| |
| Shares outstanding (basic) [+] | 0.0 | 12.4 | 5.2 | 0.9 | 6.8 | 0.3 |
| Growth | -100.0% | 136.9% | 452.0% | -86.0% | 1900.3% | |
| Shares outstanding (diluted) [+] | 0.0 | 12.4 | 5.2 | 0.9 | 6.8 | 0.3 |
| Growth | -100.0% | 136.9% | 452.0% | -86.0% | 1900.3% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |